Sectoral Asset Management’s Royalty Pharma RPRX Stock Holding History

Sectoral Asset Management’s Portfolio RPRX Stock Details RPRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$394K	Sell	7,200 -1,270	-15%	-$55.6K	0.33%	62
2025 Q4	$327K	Sell	8,470 -810	-9%	-$30.9K	0.26%	67
2025 Q3	$327K	Hold	9,280	–	–	0.2%	73
2025 Q2	$334K	Hold	9,280	–	–	0.22%	78
2025 Q1	$289K	Buy	9,280 +2,080	+29%	+$65.9K	0.22%	64
2024 Q4	$184K	Sell	7,200 -9,230	-56%	-$245K	0.12%	79
2024 Q3	$465K	Sell	16,430 -220	-1%	-$6.09K	0.27%	66
2024 Q2	$439K	Sell	16,650 -2,770	-14%	-$76.8K	0.18%	70
2024 Q1	$590K	Sell	19,420 -1,150	-6%	-$33.9K	0.23%	63
2023 Q4	$578K	Buy	20,570 +2,620	+15%	+$72K	0.25%	72
2023 Q3	$487K	Buy	17,950 +2,588	+17%	+$76.9K	0.09%	107
2023 Q2	$472K	Buy	15,362 +2,922	+23%	+$99K	0.08%	108
2023 Q1	$448K	Hold	12,440	–	–	0.09%	104
2022 Q4	$492K	Buy	12,440 +300	+2%	+$12.5K	0.1%	103
2022 Q3	$488K	Sell	12,140 -1,700	-12%	-$72.6K	0.1%	88
2022 Q2	$582K	Buy	+13,840	New	+$567K	0.12%	91

Other funds holding RPRX

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

Sectoral Asset Management's RPRX Position: Q1 2026 in Review

Sectoral Asset Management reduced its Royalty Pharma (RPRX) stake by 15% in Q1 2026, selling an estimated $55.6K and leaving 7,200 shares worth $394K. The position accounts for 0.33% of the portfolio, ranked #62.

Sectoral Asset Management first reported a position in RPRX in Q2 2022 and has held it in 16 quarters since. The position peaked at $590K in Q1 2024. 587 funds tracked by Wall St. Rank hold RPRX as of Q1 2026.

Sectoral Asset Management held 7,200 shares of Royalty Pharma worth $394K as of Q1 2026.
Sectoral Asset Management sold 1,270 Royalty Pharma shares in Q1 2026, an estimated $55.6K.
Royalty Pharma made up 0.33% of Sectoral Asset Management's portfolio in Q1 2026, its #62 holding.
Sectoral Asset Management first reported a position in Royalty Pharma in Q2 2022 and has held it in 16 quarters since.
Sectoral Asset Management's Royalty Pharma position peaked at $590K in Q1 2024.
587 funds tracked by Wall St. Rank held Royalty Pharma as of Q1 2026.

Based on Sectoral Asset Management's 13F filing for Q1 2026, filed 15 May 2026.